ScripSun’s founder and managing director Dilip Shanghvi is handing over day-to-day leadership charge to company longtimer Kirti Ganorkar in what the Indian firm termed as the culmination of a “structured a
Generics BulletinSun signaled launch action ahead in the US and a change in plan for certain pipeline specialty assets, even as it awaits, like other industry peers , more clarity on details around US President Don
ScripSun signaled launch action ahead in the US and a change in plan for certain pipeline specialty assets, even as it awaits, like other industry peers , more clarity on details around US President Don
ScripUS President Donald Trump’s ever-evolving stance on tariffs may be rattling the world and also has pharma on tenterhooks, but going down that path for generic medicines may be a doubled-edged sword or